exchange select recall
FDA recall D-0456-2026 · initiated Mar 20, 2026
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalled exchange select in Mar 2026 — an FDA Class II recall (D-0456-2026) because This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
The manufacturing process itself
The FDA found the process itself out of compliance, usually before any defective product was identified.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: N/A
Details
- Product
- exchange select, Menthol -Cough Suppressant Oral Anesthetic, Honey Lemon Flavor Cough Drops, 30-count bag, Manufactured for Your Military Exchanges By: Medical Group Care, LLC., 1035 Collier Center Way, STE 5, Naples, FL, Made in China, NDC 83698-580-30, UPC: 614299398870.
- Recalling company
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide.
- Initiated
- Mar 20, 2026
- FDA report date
- Apr 22, 2026
Frequently asked
- Was exchange select recalled?
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalled exchange select in Mar 2026 — an FDA Class II recall (D-0456-2026) because This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was exchange select recalled?
- Per the FDA enforcement record, the reason for recall D-0456-2026 was: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- Is a recalled exchange select dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of exchange select are affected?
- Distributed: US Nationwide.. The recall covers these lots — Lot # 20241030, Exp Date: 10/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0456-2026.